Skip to main content
CBIO
NASDAQ Life Sciences

Crescent Biopharma Launches Underwritten Public Offering, Diluting Existing Shareholders

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$14.55
Mkt Cap
$421.988M
52W Low
$8.72
52W High
$27.41
52W Position info
67% above low
Off High info
47% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

CBIO sits 67% above its 52-week low of $8.72 on light trading volume (0.2× avg).

Summary

Crescent Biopharma has commenced an underwritten public offering of ordinary shares and pre-funded warrants, with a 15% overallotment option. The size and price are not yet disclosed, but the offering is separate from the $200M at-the-market program filed on July 1. This follows the recent S-3 shelf registration and comes as the company reported Q2 cash of $171.6 million, down $17.6 million from Q1. The offering will dilute existing shareholders and signals a need for additional capital beyond the ATM. The involvement of multiple bulge-bracket banks suggests significant size, likely pressuring the stock. Terms will be set after marketing; watch for pricing details in the coming days.

At the time of this announcement, CBIO was trading at $14.55 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $422M. The 52-week trading range was $8.72 to $27.41. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CBIO - Latest Insights

CBIO
Nov 12, 2026, 4:15 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $14.37
Real-time Price: $13.44 info
Change: -$0.935 (-7%) info
Market Cap: $522.56M info
CBIO
Nov 12, 2026, 4:11 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.37
Real-time Price: $13.44 info
Change: -$0.935 (-7%) info
Market Cap: $522.56M info
CBIO
Oct 15, 2026, 4:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.47
Real-time Price: $13.44 info
Change: +$0.965 (+8%) info
Market Cap: $522.56M info
CBIO
Oct 05, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $14.91
Real-time Price: $13.44 info
Change: -$1.47 (-10%) info
Market Cap: $522.56M info
CBIO
Jul 30, 2026, 9:25 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.77
Real-time Price: $13.44 info
Change: -$1.33 (-9%) info
Market Cap: $522.56M info